ES2309996T3 - Nueva proteina de fusion, gen que la codifica, vector recombinante, virus recombinante, y su uso. - Google Patents

Nueva proteina de fusion, gen que la codifica, vector recombinante, virus recombinante, y su uso. Download PDF

Info

Publication number: ES2309996T3
Authority: ES; Spain
Prior art keywords: virus; polypeptide; protein; recombinant; outer membrane
Prior art date: 1996-03-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES97914561T

Other languages

English (en)

Spanish (es)

Inventor

Shuji Nippon Zeon Co. Ltd. SAITO

Yoshinari Nippon Zeon Co. Ltd. TSUZAKI

Noboru Nippon Zeon Co. Ltd. Yanagida

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Zeon Corp

Original Assignee

Zeon Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-29

Filing date

1997-03-28

Publication date

2008-12-16

1997-03-28 Application filed by Zeon Corp filed Critical Zeon Corp

2008-12-16 Application granted granted Critical

2008-12-16 Publication of ES2309996T3 publication Critical patent/ES2309996T3/es

2017-03-28 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108020001507 fusion proteins Proteins 0.000 title claims abstract description 22
241000700605 Viruses Species 0.000 title abstract description 40
108090000623 proteins and genes Proteins 0.000 claims abstract description 73
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 61
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 59
229920001184 polypeptide Polymers 0.000 claims abstract description 57
102000004169 proteins and genes Human genes 0.000 claims abstract description 44
241000204022 Mycoplasma gallisepticum Species 0.000 claims abstract description 24
239000012528 membrane Substances 0.000 claims abstract description 20
229960005486 vaccine Drugs 0.000 claims abstract description 16
241000700647 Variola virus Species 0.000 claims description 31
241000271566 Aves Species 0.000 claims description 29
241001529453 unidentified herpesvirus Species 0.000 claims description 28
101710116435 Outer membrane protein Proteins 0.000 claims description 26
229940031567 attenuated vaccine Drugs 0.000 claims description 23
102000037865 fusion proteins Human genes 0.000 claims description 20
208000015181 infectious disease Diseases 0.000 claims description 13
108010076504 Protein Sorting Signals Proteins 0.000 claims description 9
241000701047 Gallid alphaherpesvirus 2 Species 0.000 claims description 7
244000144977 poultry Species 0.000 claims description 7
210000002966 serum Anatomy 0.000 claims description 7
241000204003 Mycoplasmatales Species 0.000 claims description 5
230000002238 attenuated effect Effects 0.000 claims description 4
230000004927 fusion Effects 0.000 claims description 4
238000006243 chemical reaction Methods 0.000 claims description 3
239000004615 ingredient Substances 0.000 claims description 2
230000002924 anti-infective effect Effects 0.000 claims 3
-1 nti-infection Species 0.000 claims 1
238000002360 preparation method Methods 0.000 abstract description 3
241000700663 Avipoxvirus Species 0.000 abstract 1
230000002725 anti-mycoplasma Effects 0.000 abstract 1
108020004414 DNA Proteins 0.000 description 42
238000000034 method Methods 0.000 description 31
239000012634 fragment Substances 0.000 description 28
210000004027 cell Anatomy 0.000 description 26
241000287828 Gallus gallus Species 0.000 description 22
235000013330 chicken meat Nutrition 0.000 description 22
239000013612 plasmid Substances 0.000 description 19
210000004379 membrane Anatomy 0.000 description 17
230000000890 antigenic effect Effects 0.000 description 16
241000712469 Fowl plague virus Species 0.000 description 12
102000003960 Ligases Human genes 0.000 description 9
108090000364 Ligases Proteins 0.000 description 9
238000010276 construction Methods 0.000 description 9
101100101156 Caenorhabditis elegans ttm-1 gene Proteins 0.000 description 8
241000204031 Mycoplasma Species 0.000 description 8
238000011081 inoculation Methods 0.000 description 8
150000001413 amino acids Chemical class 0.000 description 7
108091008146 restriction endonucleases Proteins 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
230000029087 digestion Effects 0.000 description 6
239000000725 suspension Substances 0.000 description 6
241000700584 Simplexvirus Species 0.000 description 5
239000000427 antigen Substances 0.000 description 5
102000036639 antigens Human genes 0.000 description 5
108091007433 antigens Proteins 0.000 description 5
230000003902 lesion Effects 0.000 description 5
239000000243 solution Substances 0.000 description 5
229920001817 Agar Polymers 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
102000003886 Glycoproteins Human genes 0.000 description 4
108090000288 Glycoproteins Proteins 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
238000007792 addition Methods 0.000 description 4
239000008272 agar Substances 0.000 description 4
125000003275 alpha amino acid group Chemical group 0.000 description 4
238000012217 deletion Methods 0.000 description 4
230000037430 deletion Effects 0.000 description 4
101150029683 gB gene Proteins 0.000 description 4
235000013594 poultry meat Nutrition 0.000 description 4
239000013049 sediment Substances 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
241000700667 Pigeonpox virus Species 0.000 description 3
210000004102 animal cell Anatomy 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
239000006285 cell suspension Substances 0.000 description 3
230000006378 damage Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000005755 formation reaction Methods 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
229940031551 inactivated vaccine Drugs 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000002265 prevention Effects 0.000 description 3
230000006798 recombination Effects 0.000 description 3
238000005215 recombination Methods 0.000 description 3
239000002356 single layer Substances 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
238000012546 transfer Methods 0.000 description 3
238000005406 washing Methods 0.000 description 3
101000583086 Bunodosoma granuliferum Delta-actitoxin-Bgr2b Proteins 0.000 description 2
241001643084 Cyrtanthus elatus virus A Species 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
206010028470 Mycoplasma infections Diseases 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
206010037888 Rash pustular Diseases 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
241000385708 Turkeypox virus Species 0.000 description 2
241000700618 Vaccinia virus Species 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
239000002253 acid Substances 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
235000013601 eggs Nutrition 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
230000036039 immunity Effects 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
208000014674 injury Diseases 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
239000002773 nucleotide Substances 0.000 description 2
125000003729 nucleotide group Chemical group 0.000 description 2
RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
208000029561 pustule Diseases 0.000 description 2
238000007790 scraping Methods 0.000 description 2
235000020183 skimmed milk Nutrition 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
101150074875 ttm-1 gene Proteins 0.000 description 2
238000001262 western blot Methods 0.000 description 2
LINMATFDVHBYOS-MBJXGIAVSA-N (2s,3r,4s,5r,6r)-2-[(5-bromo-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C=C12 LINMATFDVHBYOS-MBJXGIAVSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
241000272201 Columbiformes Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
208000000666 Fowlpox Diseases 0.000 description 1
241000700662 Fowlpox virus Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
101150008820 HN gene Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
208000006758 Marek Disease Diseases 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241001545525 Mycoplasma gallisepticum S6 Species 0.000 description 1
AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
208000010359 Newcastle Disease Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
101150003725 TK gene Proteins 0.000 description 1
206010051867 Tracheal injury Diseases 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000008859 change Effects 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000007547 defect Effects 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
239000003651 drinking water Substances 0.000 description 1
235000020188 drinking water Nutrition 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000012447 hatching Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000007689 inspection Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229960002337 magnesium chloride Drugs 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000002609 medium Substances 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
235000019796 monopotassium phosphate Nutrition 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
230000035772 mutation Effects 0.000 description 1
238000002663 nebulization Methods 0.000 description 1
229940105631 nembutal Drugs 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
230000017448 oviposition Effects 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
230000018883 protein targeting Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000028327 secretion Effects 0.000 description 1
229940083538 smallpox vaccine Drugs 0.000 description 1
239000002904 solvent Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
125000003831 tetrazolyl group Chemical group 0.000 description 1
238000010257 thawing Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000014616 translation Effects 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

ES97914561T 1996-03-29 1997-03-28 Nueva proteina de fusion, gen que la codifica, vector recombinante, virus recombinante, y su uso. Expired - Lifetime ES2309996T3 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP8-103548		1996-03-29
JP10354896		1996-03-29

Publications (1)

Publication Number	Publication Date
ES2309996T3 true ES2309996T3 (es)	2008-12-16

Family

ID=14356886

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES97914561T Expired - Lifetime ES2309996T3 (es)	1996-03-29	1997-03-28	Nueva proteina de fusion, gen que la codifica, vector recombinante, virus recombinante, y su uso.

Country Status (7)

Country	Link
US (1)	US7348422B2 (fr)
EP (1)	EP0905140B9 (fr)
JP (1)	JP3357071B2 (fr)
AU (1)	AU2176997A (fr)
DE (1)	DE69738977D1 (fr)
ES (1)	ES2309996T3 (fr)
WO (1)	WO1997036924A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1294771T3 (da) *	2000-06-12	2008-12-15	Univ Saskatchewan	Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering
US20030059799A1 (en) *	2001-07-11	2003-03-27	Takashi Okuda	Modified DNA molecule, recombinant containing the same, and uses thereof
US6936707B2 (en)	2001-07-11	2005-08-30	Zeon Corporation	Modified DNA molecule, recombinant containing the same, and uses thereof
CN105567648B (zh)	2009-04-15	2019-09-03	法国诗华大药厂	用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗
EP2789346A1 (fr)	2013-04-11	2014-10-15	CEVA Santé Animale SA	Vaccins et polypeptides de fusion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5286639A (en)	1987-09-16	1994-02-15	Nippon Zeon Co., Ltd.	Recombinant avipoxvirus
CA1339260C (fr) *	1988-06-02	1997-08-12	Kazumi Kodama	Antigenes de mycoplasma gallisepticum et vecteurs recombinants renfermant le gene; agents de diagnostic et vaccins utilisant ces antigenes
JP2781605B2 (ja) *	1989-06-22	1998-07-30	日本ゼオン株式会社	組み換えアビポックスウイルス
GB8915870D0 (en) *	1989-07-11	1989-08-31	Nat Res Dev	Dna coding for a polypeptide signal sequence in vaccinia virus
CA2127700C (fr) *	1992-01-13	2006-06-20	Enzo Paoletti	Vaccin recombinant a base de poxvirus et de virus de la maladie de marek
AU691175B2 (en)	1993-03-31	1998-05-14	Nippon Zeon Co., Ltd.	Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof

1997
- 1997-03-28 DE DE69738977T patent/DE69738977D1/de not_active Expired - Fee Related
- 1997-03-28 US US09/147,052 patent/US7348422B2/en not_active Expired - Fee Related
- 1997-03-28 WO PCT/JP1997/001084 patent/WO1997036924A1/fr not_active Ceased
- 1997-03-28 ES ES97914561T patent/ES2309996T3/es not_active Expired - Lifetime
- 1997-03-28 AU AU21769/97A patent/AU2176997A/en not_active Abandoned
- 1997-03-28 JP JP53512997A patent/JP3357071B2/ja not_active Expired - Lifetime
- 1997-03-28 EP EP97914561A patent/EP0905140B9/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0905140B9 (fr)	2009-05-13
US7348422B2 (en)	2008-03-25
AU2176997A (en)	1997-10-22
JP3357071B2 (ja)	2002-12-16
EP0905140B1 (fr)	2008-09-10
WO1997036924A1 (fr)	1997-10-09
EP0905140A1 (fr)	1999-03-31
EP0905140A4 (fr)	2000-12-06
US20010014335A1 (en)	2001-08-16
DE69738977D1 (de)	2008-10-23

Publication	Publication Date	Title
KR20210133888A (ko)	2021-11-08	사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물
JP2577280B2 (ja)	1997-01-29	組換えポックスウイルス及び連鎖球菌ｍタンパク質ワクチン
JPH03502687A (ja)	1991-06-20	レスピラトリイ・シンシチアル・ウイルス：ワクチンおよび診断法
JPH08501931A (ja)	1996-03-05	コロナウイルスに対するワクチン接種用組成物および方法
JPH0690769A (ja)	1994-04-05	バキュロウイルス発現系
US5661006A (en)	1997-08-26	DNA encoding the Canine coronavirus spike protein
US5283191A (en)	1994-02-01	Mareks' disease virus vaccine
CN100582122C (zh)	2010-01-20	O型口蹄疫病毒多表位粘膜免疫疫苗及其应用
EP0484382A1 (fr)	1992-05-13	Proteine capsidique de calicivirus felin et sequence nucleotidique.
JP3045609B2 (ja)	2000-05-29	抗マレック病組み換えフォウルポックスウィルス
ES2309996T3 (es)	2008-12-16	Nueva proteina de fusion, gen que la codifica, vector recombinante, virus recombinante, y su uso.
EP0797667A1 (fr)	1997-10-01	Vaccin contre les papillomavirus
HU211673A9 (en)	1995-12-28	Coccidiosis vaccines
KR102514122B1 (ko)	2023-03-24	사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물
CA2086739A1 (fr)	1992-01-07	Vaccin a base de glycoproteines contre le ehv-4
US6322780B1 (en)	2001-11-27	Marek's disease virus vaccines for protection against Marek's disease
EP0522535B1 (fr)	2003-04-16	Virus recombinant de la maladie de Marek, procédé de préparation de celui-ci, et vaccin le contenant
CA2067469C (fr)	2003-07-01	Vaccin recombinant contre la maladie de marek
KR20220058090A (ko)	2022-05-09	D614g 변이형 사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물
HUT56136A (en)	1991-07-29	Process for producing vaccine against infectious bronchitis virus
ES2270427T3 (es)	2007-04-01	Herpresvirus transformados para la expresion de la gd in vitro.
JPWO1997036924A1 (ja)	1999-05-18	新規な融合タンパク質、その遺伝子、組み換えベクター、及び組み換えウイルスとその利用
KR20220040423A (ko)	2022-03-30	재조합 단백질을 포함하는 사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물
WO1998023754A1 (fr)	1998-06-04	Procede pour l'expression des genes des virus de la dengue
JP3428666B2 (ja)	2003-07-22	組換えマレック病ウイルスおよびその製法